Revision as of 02:03, 20 May 2011 editEmausBot (talk | contribs)Bots, Template editors2,859,937 editsm r2.6.4) (robot Adding: ar:رودانين← Previous edit | Latest revision as of 02:01, 25 December 2023 edit undo1234qwer1234qwer4 (talk | contribs)Extended confirmed users, Page movers197,955 edits added Category:Substances discovered in the 19th century using HotCat | ||
(47 intermediate revisions by 24 users not shown) | |||
Line 1: | Line 1: | ||
⚫ | {{distinguish|rhodamine}} | ||
{{chembox | {{chembox | ||
| Watchedfields = changed | |||
| verifiedrevid = |
| verifiedrevid = 464381819 | ||
|Reference=<ref> at ]</ref> | | Reference = <ref> at ]</ref> | ||
|ImageFile=Rhodanine transparant.png | |||
| ImageFile = Rhodanine.svg | |||
|ImageSize=150px | | ImageSize = 150px | ||
| |
| PIN = 2-Sulfanylidene-1,3-thiazolidin-4-one | ||
|OtherNames=2-Thioxo-4-thiazolidinone; 4-Oxo-2-thioxothiazoline | | OtherNames = 2-Thioxo-4-thiazolidinone; 4-Oxo-2-thioxothiazoline | ||
⚫ | |Section1={{Chembox Identifiers | ||
⚫ | | |
||
⚫ | |Section1 = {{Chembox Identifiers | ||
⚫ | | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ||
| ChemSpiderID = 1013337 | | ChemSpiderID = 1013337 | ||
| InChI = 1/C3H3NOS2/c5-2-1-7-3(6)4-2/h1H2,(H,4,5,6) | | InChI = 1/C3H3NOS2/c5-2-1-7-3(6)4-2/h1H2,(H,4,5,6) | ||
Line 13: | Line 17: | ||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | | ChEMBL_Ref = {{ebicite|correct|EBI}} | ||
| ChEMBL = 224633 | | ChEMBL = 224633 | ||
| EC_number = 205-505-1 | |||
| KEGG = C07280 | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | ||
| StdInChI = 1S/C3H3NOS2/c5-2-1-7-3(6)4-2/h1H2,(H,4,5,6) | | StdInChI = 1S/C3H3NOS2/c5-2-1-7-3(6)4-2/h1H2,(H,4,5,6) | ||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | ||
| StdInChIKey = KIWUVOGUEXMXSV-UHFFFAOYSA-N | | StdInChIKey = KIWUVOGUEXMXSV-UHFFFAOYSA-N | ||
| CASNo_Ref = {{cascite|correct|CAS}} | |||
| CASNo=141-84-4 | | CASNo =141-84-4 | ||
⚫ | | |
||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
⚫ | | |
||
| UNII = 7O50LKL2G8 | |||
⚫ | | PubChem =1201546 | ||
⚫ | | SMILES = O=C1NC(=S)SC1 | ||
}} | }} | ||
|Section2={{Chembox Properties | | Section2 = {{Chembox Properties | ||
| |
| C=3 | H=3 | N=1 | O=1 | S=2 | ||
| Appearance= | |||
| Appearance = | |||
| Density= | |||
| Density = 0.868 g/cm<sup>−3</sup><ref name=b1/> | |||
| MeltingPt=165-169 °C | |||
| MeltingPtC = 170 | |||
| BoilingPt= | |||
| MeltingPt_ref = <ref name=b1>{{cite book | editor= Haynes, William M. | year = 2011 | title = CRC Handbook of Chemistry and Physics | edition = 92nd | publisher = ] | isbn = 978-1439855119|page=3.512| title-link = CRC Handbook of Chemistry and Physics }}</ref> | |||
| Solubility= | |||
| BoilingPt = | |||
| Solubility = Soluble<ref name=b1/> | |||
| SolubleOther = Ethanol, dimethyl sulfoxide<ref name=b1/> | |||
}} | }} | ||
|Section3={{Chembox Hazards | | Section3 = {{Chembox Hazards | ||
| MainHazards= | |||
| MainHazards = | |||
| FlashPt= | |||
| FlashPt = | |||
| Autoignition= | |||
| AutoignitionPt = | |||
| EUClass = {{Hazchem Xn}} | |||
| |
| GHSPictograms = {{GHS05}}{{GHS07}} | ||
| GHSSignalWord = Danger | |||
| SPhrases = {{S22}} {{S26}} {{S39}} | |||
| HPhrases = {{H-phrases|302|318}} | |||
| PPhrases = {{P-phrases|264|270|280|301+312|305+351+338|310|330|501}} | |||
}} | }} | ||
}} | }} | ||
⚫ | {{distinguish|rhodamine}} | ||
⚫ | |||
'''Rhodanine''' is a 5-membered ] ] possessing a ] core. It was discovered in 1877 by ] who named it ''"Rhodaninsaure"'' in reference to its synthesis from ammonium rhodanide (known as ] to modern chemists) and ] in water.<ref>{{cite journal|last1=Nencki|first1=M.|title=Ueber die Einwirkung der Monochloressigsäure auf Sulfocyansäure und ihre Salze|journal=Journal für Praktische Chemie|date=10 July 1877|volume=16|issue=1|pages=1–17|doi=10.1002/prac.18770160101|url=https://zenodo.org/record/1427872}}</ref> | |||
Some derivatives of rhodanine have pharmacological properties, such as ] which is used to treat ]. | |||
⚫ | Rhodanines can also be prepared by the reaction of ], ], and ], which proceeds via an intermediate ].<ref>{{OrgSynth | title = Rhodanine | author1 = Redemann, C. Ernst | author2 = Icke, Roland N. | author3 = Alles, Gordon A. | year = 1955 | collvol = 3 | collvolpages = 763 | prep = cv3p0763 }}</ref> | ||
:] | |||
==Derivatives== | |||
Some rhodanine ] have pharmacological properties; for instance, ] is used to treat ]. However, most are promiscuous binders with poor selectivity; as a result, this class of compounds is viewed with suspicion by medicinal chemists.<ref>{{cite journal | journal = J. Med. Chem. | year = 2010 | volume = 53 | pages = 2719–2740 | doi = 10.1021/jm901137j | pmid = 20131845 | title = New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays | issue = 7| last1 = Baell | first1 = J. B | last2 = Holloway | first2 = G. A | citeseerx = 10.1.1.394.9155 }}</ref><ref>{{cite journal | doi = 10.1517/17460441.2012.688743 | pmid = 22607309 | title = Rhodanine as a scaffold in drug discovery: A critical review of its biological activities and mechanisms of target modulation | year = 2012 | last1 = Tomašić | first1 = Tihomir | last2 = Peterlin Mašič | first2 = Lucija | journal = Expert Opinion on Drug Discovery | pages = 549–60 | volume=7| issue = 7 | s2cid = 3401210 }}</ref><ref>{{cite journal|last1=Pouliot|first1=Martin|last2=Jeanmart|first2=Stephane|title=Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research|journal=Journal of Medicinal Chemistry|date=8 September 2015|pages=497–503|doi=10.1021/acs.jmedchem.5b00361|volume=59|issue=2|pmid=26313340}}</ref> Differing academic opinions exist concerning the correct use of ] filters, the necessity of the experimental confirmations of such properties, and many useful features of rhodanine derivatives.<ref>{{cite journal | journal = Expert Opinion on Drug Discovery | year = 2017 | volume = 12 | pages = 1233–1252 | doi = 10.1080/17460441.2017.1388370 | pmid = 29019278 | title = Recent developments with rhodanine as a scaffold for drug discovery | issue = 12| last1 = Kaminskyy | first1 = D | last2 = Kryshchyshyn | first2 = A | last3 = Lesyk | first3 = R | s2cid = 3514481 }}</ref><ref>{{cite journal | journal = Eur. J. Med. Chem. | year = 2017 | volume = 140 | pages = 542–594 | doi = 10.1016/j.ejmech.2017.09.031 | pmid = 28987611 | title = 5-Ene-4-thiazolidinonese An efficient tool in medicinal chemistry | issue = 10| last1 = Kaminskyy | first1 = D | last2 = Kryshchyshyn | first2 = A | last3 = Lesyk | first3 = R | pmc = 7111298 }}</ref> | |||
==References== | ==References== | ||
Line 47: | Line 66: | ||
] | ] | ||
] | ] | ||
] | |||
] | |||
] |
Latest revision as of 02:01, 25 December 2023
Not to be confused with rhodamine.Names | |
---|---|
Preferred IUPAC name 2-Sulfanylidene-1,3-thiazolidin-4-one | |
Other names 2-Thioxo-4-thiazolidinone; 4-Oxo-2-thioxothiazoline | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.005.005 |
EC Number |
|
KEGG | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C3H3NOS2 |
Molar mass | 133.18 g·mol |
Density | 0.868 g/cm |
Melting point | 170 °C (338 °F; 443 K) |
Solubility in water | Soluble |
Solubility | Ethanol, dimethyl sulfoxide |
Hazards | |
GHS labelling: | |
Pictograms | |
Signal word | Danger |
Hazard statements | H302, H318 |
Precautionary statements | P264, P270, P280, P301+P312, P305+P351+P338, P310, P330, P501 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references |
Rhodanine is a 5-membered heterocyclic organic compound possessing a thiazolidine core. It was discovered in 1877 by Marceli Nencki who named it "Rhodaninsaure" in reference to its synthesis from ammonium rhodanide (known as ammonium thiocyanate to modern chemists) and chloroacetic acid in water.
Rhodanines can also be prepared by the reaction of carbon disulfide, ammonia, and chloroacetic acid, which proceeds via an intermediate dithiocarbamate.
Derivatives
Some rhodanine derivatives have pharmacological properties; for instance, epalrestat is used to treat diabetic neuropathy. However, most are promiscuous binders with poor selectivity; as a result, this class of compounds is viewed with suspicion by medicinal chemists. Differing academic opinions exist concerning the correct use of PAINS filters, the necessity of the experimental confirmations of such properties, and many useful features of rhodanine derivatives.
References
- Rhodanine at Sigma-Aldrich
- ^ Haynes, William M., ed. (2011). CRC Handbook of Chemistry and Physics (92nd ed.). CRC Press. p. 3.512. ISBN 978-1439855119.
- Nencki, M. (10 July 1877). "Ueber die Einwirkung der Monochloressigsäure auf Sulfocyansäure und ihre Salze". Journal für Praktische Chemie. 16 (1): 1–17. doi:10.1002/prac.18770160101.
- Redemann, C. Ernst; Icke, Roland N.; Alles, Gordon A. (1955). "Rhodanine". Organic Syntheses; Collected Volumes, vol. 3, p. 763.
- Baell, J. B; Holloway, G. A (2010). "New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays". J. Med. Chem. 53 (7): 2719–2740. CiteSeerX 10.1.1.394.9155. doi:10.1021/jm901137j. PMID 20131845.
- Tomašić, Tihomir; Peterlin Mašič, Lucija (2012). "Rhodanine as a scaffold in drug discovery: A critical review of its biological activities and mechanisms of target modulation". Expert Opinion on Drug Discovery. 7 (7): 549–60. doi:10.1517/17460441.2012.688743. PMID 22607309. S2CID 3401210.
- Pouliot, Martin; Jeanmart, Stephane (8 September 2015). "Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research". Journal of Medicinal Chemistry. 59 (2): 497–503. doi:10.1021/acs.jmedchem.5b00361. PMID 26313340.
- Kaminskyy, D; Kryshchyshyn, A; Lesyk, R (2017). "Recent developments with rhodanine as a scaffold for drug discovery". Expert Opinion on Drug Discovery. 12 (12): 1233–1252. doi:10.1080/17460441.2017.1388370. PMID 29019278. S2CID 3514481.
- Kaminskyy, D; Kryshchyshyn, A; Lesyk, R (2017). "5-Ene-4-thiazolidinonese An efficient tool in medicinal chemistry". Eur. J. Med. Chem. 140 (10): 542–594. doi:10.1016/j.ejmech.2017.09.031. PMC 7111298. PMID 28987611.